Biointerface Membrane Spacer for Implantable Sensor Accuracy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current implantable glucose monitoring devices face challenges in providing reliable and safe data for extended periods due to issues with fluid bulk, bulk fluid flow, and diffusion rates around the sensor, leading to noise and reduced accuracy.
Innovation Solution
The use of a biointerface membrane with a spacer, such as a porous polymer membrane or hydrogel, to promote increased fluid bulk and bulk fluid flow, and the incorporation of bioactive agents to enhance vascularization and wound healing, thereby reducing noise and improving sensor accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If a conventional implantable sensor is used without a biointerface membrane, then the device structure is simpler, but the sensor experiences noise and reduced accuracy due to insufficient fluid bulk, poor bulk fluid flow, and low diffusion rates around the sensor
Solution Approach 1:
A biointerface membrane is introduced as an intermediary component between the sensor and the surrounding tissue environment. This membrane incorporates spacers that create increased fluid bulk and enhance bulk fluid flow around the sensor, thereby improving analyte transport and reducing noise without requiring complex restructuring of the entire device
Solution Approach 2:
The biointerface membrane utilizes porous materials with controlled pore sizes and distributions to facilitate enhanced diffusion rates of analytes (such as glucose and oxygen) to the sensor surface. The porous structure allows efficient mass transport while maintaining the membrane's structural integrity and biocompatibility
2Duration of action of moving object
If the sensor is implanted for extended periods, then more data can be collected, but the sensor reliability decreases due to tissue response, wound healing, and formation of barrier layers around the sensor
Solution Approach 1:
The biointerface membrane is designed to preemptively address tissue response issues before they compromise sensor function. By incorporating spacers and porous structures that maintain fluid bulk and flow from the outset, the membrane prevents the formation of barrier layers and reduces the impact of wound healing processes before they can interfere with analyte transport
Solution Approach 2:
The membrane modifies local physiological parameters around the sensor, including maintaining optimal fluid bulk volume, enhancing bulk fluid flow velocity, and increasing diffusion coefficients through its porous structure. These parameter changes create a favorable microenvironment that sustains sensor reliability over extended implantation periods
3Ease of manufacture
If no biointerface membrane is used, then the device is easier to manufacture, but the sensor experiences noise due to interferant concentrations and insufficient oxygen and glucose transport
Solution Approach 1:
The biointerface membrane serves as a mediator that filters and manages the interaction between the sensor and the surrounding biological environment. It reduces interferant concentrations near the sensor while maintaining efficient transport of target analytes, thereby reducing noise without complicating the manufacturing process significantly
Solution Approach 2:
The porous structure of the membrane is engineered to selectively facilitate the transport of oxygen and glucose while restricting or filtering out interferants that could cause noise. The pore size distribution and material composition are optimized to achieve this selective transport function
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biointerface membrane creates a fluid pocket around the sensor, increasing oxygen and glucose transport and reducing interferant concentrations, leading to improved sensor performance and extended reliable data collection.
Implementation Method 1
increasing fluid bulk surrounding at least a portion of the sensor in vivo
Implementation Method 2
increasing bulk fluid flow surrounding at least a portion of the sensor in vivo
Implementation Method 3
increasing diffusion rates surrounding at least a portion of the sensor in vivo
Implementation Method 4
increasing oxygen and glucose transport
Data Source
AI summary
Biointerface membranes are provided which can be utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. More particularly, methods for monitoring glucose levels in a biological fluid sample using an implantable analyte detection device incorporating such membranes are provided.